麻豆视频

Market Trends and Insights

Rising Endoscopy Procedures: Aging Demographics Fuel Demand

An expanding elderly population and broader cancer-screening guidelines are driving double-digit increases in GI and respiratory scope use, giving the endoscope reprocessing market sustained tailwinds. More than 20 million GI examinations are performed annually^{[1]Ruixue Hu et al., 鈥淐urrent Management Status of Cleaning and Disinfection for Gastrointestinal Endoscopy,鈥� Scientific Reports, nature.com} in the United States alone, according to a 2024 meta-analysis. Higher procedural throughput obliges facilities to invest in additional reprocessing capacity, rapid turnaround detergents and leak-testing tools that uphold sterility for every cycle.

Minimally Invasive Surgery: Scope Turnover Drives Reprocessing Innovation

Ambulatory surgery centers rely on tight scheduling and quick scope turnaround to remain profitable. A LEAN workflow pilot^{[2]Trilokesh Kidambi et al., 鈥淟EAN Methodology to Improve Endoscopy Unit Efficiency,鈥� Cureus, cureus.com} cut waiting-room time by 48.8% and reduced total facility time by 12%. These gains highlight why the endoscope reprocessing market increasingly favors fully automated washers, drying cabinets and real-time tracking software that shorten bottlenecks without compromising infection-control protocols.

Infection-Control Standards: Regulatory Pressure Transforms Practices

Guideline updates from AAMI and the American Society for Gastrointestinal Endoscopy now recommend sterilizing all flexible scopes to eliminate biofilm and multidrug-resistant organisms. Studies reveal that 5.4% of clinically used duodenoscopes remain contaminated even after standard cycles. In response, healthcare systems are recalibrating protocols to favor vaporized hydrogen peroxide, peracetic acid sterilizers and rigorous validation tests.

Automated Reprocessing: Technology Reduces Human Error

State-of-the-art automated endoscope reprocessors (AERs) integrate channel-specific flow control, leak testing and barcode-driven cycle selection, removing variability associated with manual processes. The FDA^{[3]U.S. Food and Drug Administration, 鈥淚nformation 麻豆视频 Automated Endoscope Reprocessors,鈥� fda.gov} underscores their value in lowering infection risk from complex duodenoscopes. STERIS鈥檚 en spire 3000 delivers liquid chemical sterilization using peracetic acid in minutes, positioning automation as a principal growth vector in the endoscope reprocessing market.

Workforce Challenges: Technician Shortages Impede Implementation

Effective cleaning demands specialized knowledge of scope architecture and channel brushing techniques. Yet many hospitals struggle to recruit and retain certified staff,^{[4]Cori L. Ofstead et al., 鈥淓ndoscope Processing Effectiveness,鈥� American Journal of Infection Control, ajicjournal.org} with error-prone steps contributing to notable contamination events. Although automation offsets some manual tasks, qualified personnel remain indispensable for inspection, trouble-shooting and quality assurance across the endoscope reprocessing market.

Cost Barriers: Financial Constraints Limit Technology Adoption

Capital-intensive AERs, drying cabinets and tracking software strain budgets at small hospitals and clinics. Dual-basin reprocessors are preferred but command premium prices and recurring consumable costs. Facilities in emerging economies often extend the life of legacy washers or rely on manual methods, slowing modernization even as guideline expectations climb.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Endoscope Reprocessing Market Segment Analysis

High-level disinfectants and indicator strips hold a 31.68% endoscope reprocessing market share in 2025, reflecting the historical reliance on chemical HLD for flexible scopes. Novel enzymatic detergents that eliminate rinse steps now save nearly 25 L of water and cut manual cleaning time by 15%. Yet outbreaks linked to residual biofilm are steering infection-control committees toward sterilants such as vaporized hydrogen peroxide and peracetic acid. This shift boosts demand for integrated washer-sterilizers that complete validated cycles without operator adjustment, a key performance criterion as accreditation audits intensify.

Automated endoscope reprocessors are the fastest-growing product group at a 10.31% CAGR, propelling the overall endoscope reprocessing market. Vendors emphasize closed-loop documentation, RFID tagging and cloud-based analytics that record every scope serial number, cycle parameters and leak-test result. Drying and storage cabinets also gain prominence; systems such as WASSENBURG DRY 320 preserve microbiological quality for 30 days under HEPA-filtered airflow. Together, these products help facilities demonstrate compliance and reduce costly re-processing failures.

Flexible endoscopes commanded 71.10% of 2025 revenue, underpinning the current endoscope reprocessing market size at the modality level. Owing to their reach and articulation, they remain indispensable across GI, respiratory, ENT, and urology suites. However, their complexity makes them vulnerable to channel debris. Structured borescope inspections and fluorescence markers are thus being adopted to affirm cleaning efficacy.

Robot-assisted endoscopes are projected to rise 11.12% annually through 2031, carving new opportunities in the endoscope reprocessing market. Two-armed robotic colonoscopes and multi-visceral surgical robots promise enhanced ergonomics and autonomy. Their adoption will demand dedicated washer racks, protocol modifications, and staff retraining. Rigid scopes retain a stable niche for arthroscopy and laparoscopy, benefiting from simpler lumens that sterilize reliably in steam autoclaves.

Gastrointestinal procedures generated 47.30% of revenue in 2025 and anchor the endoscope reprocessing market size for applications. Colonoscopy volumes expand as universal screening begins at age 45 in several countries, accelerating scope turnover. Subsequent high-profile incidents exposing patients to HIV and hepatitis due to lapses have driven hospitals to audit every cleaning phase. Facilities now incorporate automated channel flushing and real-time ATP bioluminescence tests to safeguard GI workflows.

Pulmonology and bronchoscopy represent the fastest-growing category with an 10.62% CAGR, reflecting heightened focus on chronic respiratory diseases and critical-care bronchoscopy. Visualization reviews underscore frequent contamination of reusable bronchoscopes when drying is incomplete. Single-use flexible bronchoscopes bypass the need for reprocessing and have recorded strong clinical acceptance in bronchoalveolar lavage studies. ENT, urology, and gynecology remain steady contributors, each confronting procedure-specific biofilm challenges that shape detergent selection and drying protocols.

Hospitals accounted for 67.05% of 2025 revenue, reflecting centralized capability, 24-hour staffing and the budget latitude to deploy multiple AERs per cleaning room. Meta-analysis indicates 76% of facilities maintain separate decontamination rooms yet just 30% utilize washer-disinfectors. Integrating electronic tracking dashboards helps infection-control teams reconcile scope usage logs with reprocessing data, reducing recall response times when contamination alerts arise.

ASCs are forecast to post a 9.88% CAGR, redirecting procedure mix away from inpatient settings and expanding the endoscope reprocessing market. Higher CMS reimbursement (+2.9% for 2025) encourages adoption of compact, dual-basin reprocessors tailored to outpatient footprints. Single-day throughput necessitates rapid drying cabinets and on-cart transport systems that preserve sterility until patient contact. Physician offices and specialty clinics, although smaller in absolute revenue, increasingly invest in tabletop washers and pre-filled sterilant cartridges that minimize staff burden.

Geography Analysis

North America Endoscope Reprocessing Market

North America held 40.30% of 2025 revenue, supported by high procedural volumes and rigorous oversight from the FDA, CDC and accreditation bodies. A spotlight on infection outbreaks at leading centers has intensified demand for traceable, automated workflows and for vaporized hydrogen peroxide cabinets capable of sterilizing duodenoscopes within 35 minutes. Regional growth is projected at an 7.92% CAGR through 2031, with spending tilted toward data-rich reprocessors, borescope inspection cameras, and disposable duodenoscopes for high-risk ERCP cases.

APAC, EMEA and South America Endoscope Reprocessing Market

Asia-Pacific is the fastest-expanding territory, anticipated to advance 10.35% annually. India鈥檚 medical-device roadmap seeks USD 50 billion in sector output by 2030, with endoscopy systems and ancillary reprocessing devices eligible for production incentives. China, Japan, and South Korea allocate capital to negative-pressure drying cabinets and channel-specific leak testers, while resource-limited Pacific Islands confront shortages of purified water and certified technicians. Europe commands roughly 29.30% of the endoscope reprocessing market, posting an 8.14% CAGR projection to 2031. EU surveillance attributes more than 3.5 million healthcare-associated infections to reusable devices each year. NHS contracts exceeding GBP 250,000 awarded in 2024 reflect hospital moves to validate decontamination equipment and ensure scope-level traceability. The Middle East & Africa and South America follow with moderate growth as tertiary centers modernize CSSD units and adopt AERs capable of handling mixed scope inventories without repeated chemical changes.

Regulatory Landscape

In the United States, automated endoscope washers, washer-disinfectors, and related reprocessing equipment are regulated as medical devices, with pathway expectations anchored in FDA 510(k) submissions and the requirement that healthcare facilities reprocess reusable devices strictly per the manufacturer instructions for use (IFU). Infection-control expectations are reinforced by CDC and HICPAC guidance for flexible endoscope reprocessing, which facilities align with accreditation and survey requirements emphasizing validated cycles, documentation, and staff training.

In Europe, the Medical Device Regulation (EU) 2017/745 (MDR) remains the governing framework as of January 1, 2026, shaping conformity assessment, post-market obligations, and the compliance burden around reprocessing workflows. Under MDR Article 17, reprocessing of single-use devices is permitted only where allowed by national law, and entities that reprocess single-use devices are treated as manufacturers under MDR, which elevates requirements for validation, risk management, and traceability and creates cross-country variability based on Member State rules.

Market Opportunities and Future Outlook

Throughput-focused automation is increasingly pairing with auditable traceability as facilities respond to stricter reprocessing expectations while handling higher scope turnover in GI and pulmonology suites. Getinge's June 2026 launch of the Aquadis Endo 110 illustrates this direction, with faster standard cycles and embedded RFID-based program selection and traceability that support facilities tightening documentation and reducing manual steps that contribute to variability.

A second opportunity is the ongoing shift from high-level disinfection toward sterilization pathways for complex scopes, supported by platform-level cycle innovation and validated compatibility partnerships. In January 2026, Advanced Sterilization Products (ASP) received CE Mark for its ULTRA GI Cycle for duodenoscopes for use on the STERRAD 100NX Sterilizer in collaboration with FUJIFILM Healthcare Europe, reinforcing demand for validated, scope-specific cycles and complementary monitoring and compliance infrastructure inside sterile processing departments. Business models that reduce upfront capital friction, such as Ecolab's November 2025 Pay As You Go Endo Bundle combining Soluscope AERs, drying, and traceability software on a per-usage basis, also broaden addressability among ambulatory and mid-sized facilities that need standardized, reportable workflows while managing budget constraints.